| | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $180,000 ) |
| | 2024 | 2024 | TRANSGENDER EQUITY CONSULTING, INC. | 1839 STUART ST | BROOKLYN | NY | 11229 | KINGS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 4 | 6/26/2024 | NON-COMPETING CONTINUATION | $180,000 |
| | 2024 | 2023 | TRANSGENDER EQUITY CONSULTING, INC. | 1839 STUART ST | BROOKLYN | NY | 11229 | KINGS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 4 | 6/26/2024 | NON-COMPETING CONTINUATION | $0 |
| | 2024 | 2022 | TRANSGENDER EQUITY CONSULTING, INC. | 1839 STUART ST | BROOKLYN | NY | 11229 | KINGS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 4 | 6/26/2024 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $180,000 ) |
| | 2023 | 2023 | TRANSGENDER EQUITY CONSULTING, INC. | 1873 Hart St | Ridgewood | NY | 11385 | QUEENS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 3 | 6/14/2023 | NON-COMPETING CONTINUATION | $180,000 |
| | 2023 | 2022 | TRANSGENDER EQUITY CONSULTING, INC. | 1873 Hart St | Ridgewood | NY | 11385 | QUEENS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 3 | 6/14/2023 | NON-COMPETING CONTINUATION | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $180,000 ) |
| | 2022 | 2022 | TRANSGENDER EQUITY CONSULTING, INC. | 1873 HART ST | RIDGEWOOD | NY | 11385 | QUEENS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 2 | 7/20/2022 | NON-COMPETING CONTINUATION | $180,000 |
| | 2022 | 2021 | TRANSGENDER EQUITY CONSULTING, INC. | 1873 Hart St | Ridgewood | NY | 11385 | QUEENS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 01 | 1 | 12/5/2021 | ADMINISTRATIVE SUPPLEMENT ( + OR - ) (DISCRETIONARY OR BLOCK AWARDS) | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $180,000 ) |
| | 2021 | 2021 | TRANSGENDER EQUITY CONSULTING, INC. | 1873 Hart St | Ridgewood | NY | 11385 | QUEENS | USA | Acquired Immunodeficiency Syndrome (AIDS) Activity | 00 | 1 | 8/2/2021 | NEW | $180,000 |
|
|
